Effects of sevoflurane, propofol or alfaxalone on neuromuscular blockade produced by a single intravenous bolus of rocuronium in dogs

Vet Anaesth Analg. 2022 Jan;49(1):36-44. doi: 10.1016/j.vaa.2021.10.002. Epub 2021 Oct 30.

Abstract

Objective: To compare the effects of sevoflurane, propofol and alfaxalone on the neuromuscular blockade induced by a single intravenous bolus of rocuronium in dogs.

Study design: A randomized, prospective, crossover experimental study.

Animals: A total of eight adult Beagle dogs (four female, four male), weighing 8.9-15.3 kg and aged 5-7 years.

Methods: The dogs were anesthetized three times with 1.25× minimum alveolar concentration of sevoflurane (SEVO treatment) and 1.25× minimum infusion rate of propofol (PROP treatment) or alfaxalone (ALFX treatment) at intervals of ≥14 days. Neuromuscular function was monitored with train-of-four (TOF) stimulation of the peroneal nerve by acceleromyography. After recording the control TOF ratio (TOFRC), a single bolus dose of rocuronium (1 mg kg-1) was administered intravenously. The times from rocuronium administration to achieving TOF count 0 (onset time), from achieving TOF count 0 to the reappearance of TOF count 4 (clinical blockade period), from 25% to 75% of TOFRC (recovery index) and from achieving TOF count 0 to TOF ratio/TOFRC >0.9 (total neuromuscular blockade duration) were recorded.

Results: The onset time and recovery index did not differ among the treatments. The median clinical blockade period was longer in the SEVO treatment [27.3 (26.0-30.3) minutes] than in PROP [16.6 (15.4-18.0) minutes; p = 0.002] and ALFX [22.4 (18.6-23.1) minutes; p = 0.017] treatments; and longer in the ALFX treatment than in the PROP treatment (p = 0.020). The mean total neuromuscular blockade duration was longer in the SEVO treatment (43.7 ± 9.9 minutes) than in PROP (25.1 ± 2.7 minutes; p < 0.001) and ALFX (32.5 ± 8.4 minutes; p = 0.036) treatments.

Conclusions and clinical relevance: Compared with alfaxalone and propofol, sevoflurane prolonged rocuronium-induced neuromuscular blockade by a significantly greater extent in dogs.

Keywords: alfaxalone; dogs; neuromuscular blockade; propofol; rocuronium; sevoflurane.

Publication types

  • Randomized Controlled Trial, Veterinary

MeSH terms

  • Androstanols
  • Anesthetics, Inhalation*
  • Anesthetics, Intravenous
  • Animals
  • Dogs
  • Female
  • Male
  • Methyl Ethers*
  • Neuromuscular Blockade* / veterinary
  • Neuromuscular Nondepolarizing Agents* / pharmacology
  • Pregnanediones
  • Propofol* / pharmacology
  • Prospective Studies
  • Rocuronium
  • Sevoflurane

Substances

  • Androstanols
  • Anesthetics, Inhalation
  • Anesthetics, Intravenous
  • Methyl Ethers
  • Neuromuscular Nondepolarizing Agents
  • Pregnanediones
  • Sevoflurane
  • alphaxalone
  • Rocuronium
  • Propofol